Overview

A New Paradigm
The majority of patients with fragility fractures do not have BMD-defined osteoporosis. Addressing this issue, the VirtuOst test goes beyond BMD by providing CT-based measurements of both BMD and bone strength — aka Biomechanical Computed Tomography analysis (BCT). This test enables patients at high risk of fracture to be identified on the basis of having either osteoporosis or fragile bone strength, the latter capturing a subset of high-risk patients with osteopenia. Learn more about moving beyond BMD.

Clinical Decision Making
Following the practice guidelines of the International Society for Clinical Densitometry, and as cleared by the FDA, a patient identified as having either osteoporosis or fragile bone strength by BCT can be considered for pharmacologic or other treatment. Confirmation by DXA is not required. Learn more about the VirtuOst measurements.

Convenient and Cost-Effective
The VirtuOst test for BCT can be applied as an add-on analysis to most types of clinical CT exams that contain the hip and/or spine, regardless of the indication for the original CT scan. Simply send the patient's CT scan to O.N. Diagnostics and receive back a results within a week.  Learn more about how the VirtuOst test is convenient and cost-effective for patients and health care providers.

Coding and Reimbursement
BCT is nationally covered and reimbursed by Medicare as a Bone Mass Measurement, a bone mineral density test for osteoporosis. Learn more about coding and reimbursement for BCT.

CT Scans Suitable for BCT
BCT is well-suited for patients already undergoing a CT exam and who also qualify for an osteoporosis test, including those who have conditions or take medications that can weaken bone. Learn more the various CT exams that may be utilized for the VirtuOst test.

Ordering VirtuOst BCT
If you are interested in ordering VirtuOst Tests for your patients, please visit our Order VirtuOst page.